title: Severe gastrointestinal cytomegalovirus disease in two patients with renal vasculitis after immunosuppression.
abstract: Although the use of current immunosuppressive regimens has significantly improved the outcomes of autoimmune renal diseases, infectious complications remain an important clinical concern. Cytomegalovirus (CMV) infection has been shown to be one of the major causes of mortality in this group of patients. We report two cases of renal vasculitis (Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)) that developed into severe gastrointestinal CMV disease and manifested with massive small bowel bleeding, resulting in an eventual fatal outcome for one of the patients. Risk factors, pathogenesis, role of immunosuppression in the development of CMV infection, and antiviral treatment are discussed in this review. These cases highlight the need for further research to evaluate the complex mechanisms between immunosuppression and CMV occurrence as well as the role of antiviral prophylaxis in high-risk patients undergoing immunosuppressive therapies. .
authors.forename: Kian-Guan
authors.initials: KG
authors.lastname: Lee
authors.forename: Su-Hooi
authors.initials: SH
authors.lastname: Teo
authors.forename: Cynthia
authors.initials: C
authors.lastname: Lim
authors.forename: Alwin
authors.initials: A
authors.lastname: Loh
authors.forename: Viswanath
authors.initials: V
authors.lastname: Chidambaram
authors.forename: Jason
authors.initials: J
authors.lastname: Choo
mesh_terms: D003587:Cytomegalovirus; D003586:Cytomegalovirus Infections / Q000209:etiology*; D005260:Female; D005767:Gastrointestinal Diseases / Q000209:etiology / Q000821:virology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007674:Kidney Diseases / Q000188:drug therapy*; D008297:Male; D014657:Vasculitis / Q000188:drug therapy*
chemical_list: D007166:Immunosuppressive Agents